PCSA
Processa Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.06
+0.49%10
Insider buys (3m)
0
Insider sells (3m)
$50.6K
Net value (3m)
-19.2%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Aug 11, 2026 | Ng George K · director, officer: Chief Executive Officer | M-Exempt | 1,600 | $0.00 |
| Jul 30, 2026 | GUJRATHI SHEILA · director | A-Award | 12,311 | $0.00 |
| Jul 30, 2026 | GUJRATHI SHEILA · director | A-Award | 70,812 | $0.00 |
| Jul 28, 2026 | Lin Patrick · officer: Chief Business - Strategy Off | A-Award | 8,450 | $0.00 |
| Jul 28, 2026 | Guy Wendy · officer: Chief Administrative Officer | A-Award | 9,450 | $0.00 |
| Jul 28, 2026 | Baluch Khoso · director | A-Award | 33,500 | $0.00 |
| Jul 28, 2026 | Yorke Justin W · director | A-Award | 33,500 | $0.00 |
| Jul 28, 2026 | SKIBSTED RUSSELL · officer: Chief Financial Officer | A-Award | 11,883 | $0.00 |
| Jul 28, 2026 | Pannu Geraldine · director | A-Award | 33,500 | $0.00 |
| Jul 28, 2026 | Ng George K · director, officer: Chief Executive Officer | A-Award | 9,384 | $0.00 |
| Jul 28, 2026 | Neal James R · director | A-Award | 62,221 | $0.00 |
| Jul 1, 2026 | Ng George K · director, officer: Chief Executive Officer | Purchase | 3,057 | $1.93 |
| Jul 1, 2026 | Lin Patrick · officer: Chief Business - Strategy Off | Purchase | 2,106 | $1.93 |
| Jul 1, 2026 | Guy Wendy · officer: Chief Administrative Officer | Purchase | 2,436 | $1.93 |
| Jul 1, 2026 | SKIBSTED RUSSELL · officer: Chief Financial Officer | Purchase | 3,277 | $1.93 |
| Jul 1, 2026 | Young David · director, officer: Pres. Research & Development | Purchase | 2,531 | $1.93 |
| Jun 30, 2026 | Baluch Khoso · director | M-Exempt | 203 | $0.00 |
| Jun 30, 2026 | Neal James R · director | M-Exempt | 203 | $0.00 |
| Jun 30, 2026 | Pannu Geraldine · director | M-Exempt | 203 | $0.00 |
| Jun 30, 2026 | Yorke Justin W · director | M-Exempt | 203 | $0.00 |
| Jun 16, 2026 | Guy Wendy · officer: Chief Administrative Officer | Purchase | 2,118 | $2.22 |
| Jun 16, 2026 | Young David · director, officer: Pres. Research & Development | Purchase | 2,067 | $2.22 |
| Jun 16, 2026 | SKIBSTED RUSSELL · officer: Chief Financial Officer | Purchase | 2,654 | $2.22 |
| Jun 16, 2026 | Ng George K · director, officer: Chief Executive Officer | Purchase | 2,465 | $2.22 |
| Jun 16, 2026 | Lin Patrick · officer: Chief Business - Strategy Off | Purchase | 1,831 | $2.22 |
| Jun 1, 2026 | Ng George K · director, officer: Chief Executive Officer | Purchase | 2,129 | $2.57 |
| Jun 1, 2026 | Guy Wendy · officer: Chief Administrative Officer | Purchase | 1,829 | $2.57 |
| Jun 1, 2026 | Lin Patrick · officer: Chief Business - Strategy Off | Purchase | 1,582 | $2.57 |
| Jun 1, 2026 | SKIBSTED RUSSELL · officer: Chief Financial Officer | Purchase | 2,292 | $2.57 |
| Jun 1, 2026 | Young David · director, officer: Pres. Research & Development | Purchase | 1,786 | $2.57 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 11, 2026